M1069

· EMD Serono Research & Development Institute, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for M1069, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: First in Human Study of M1069 in Advanced Solid Tumors [Phase 1]